↓ Skip to main content

GCH1, BH4 and Pain

Overview of attention for article published in Current Pharmaceutical Biotechnology, October 2011
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#3 of 835)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
10 news outlets
blogs
2 blogs
twitter
1 tweeter

Citations

dimensions_citation
41 Dimensions

Readers on

mendeley
56 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
GCH1, BH4 and Pain
Published in
Current Pharmaceutical Biotechnology, October 2011
DOI 10.2174/138920111798357393
Pubmed ID
Authors

Alban Latremoliere, Michael Costigan

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 55 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 25%
Researcher 9 16%
Student > Doctoral Student 8 14%
Student > Master 5 9%
Student > Bachelor 4 7%
Other 6 11%
Unknown 10 18%
Readers by discipline Count As %
Agricultural and Biological Sciences 10 18%
Neuroscience 9 16%
Medicine and Dentistry 8 14%
Biochemistry, Genetics and Molecular Biology 8 14%
Pharmacology, Toxicology and Pharmaceutical Science 4 7%
Other 4 7%
Unknown 13 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 97. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 October 2021.
All research outputs
#291,257
of 19,430,502 outputs
Outputs from Current Pharmaceutical Biotechnology
#3
of 835 outputs
Outputs of similar age
#9,255
of 337,049 outputs
Outputs of similar age from Current Pharmaceutical Biotechnology
#1
of 16 outputs
Altmetric has tracked 19,430,502 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 835 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 337,049 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.